期刊文献+

尿转铁蛋白和胱抑素C联合检测在原发性肾小球肾炎患者早期诊断的应用 被引量:3

下载PDF
导出
摘要 目的探讨尿转铁蛋白(TRF)和耽押素C(Cysc)联合检测对肾小球疾病早期诊断的临床价值。方法选择2012年1~10月收治的住院原发性肾小球肾炎患者50例为实验组,选择同期健康体检者50例为健康对照组,比较两组的临床资料。结果实验组尿液TRF和CysC水平高于健康对照组(P〈0.05),实验组临床病理分型Ⅱ、Ⅲ、Ⅳ型患者尿液中TRF和Cys—C水平明显高于Ⅰ型,差异呈递增性增加。结论尿TRF和Cys—C联合测定有助于肾小球疾病的早期诊断,能更灵敏、更精确地反映肾小球功能受损的情况。
作者 兰飞
出处 《检验医学与临床》 CAS 2014年第2期234-235,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献9

二级参考文献28

  • 1林维平,李思光,徐琪寿.视黄醇结合蛋白的分子机制及临床应用[J].军事医学科学院院刊,2005,29(5):492-495. 被引量:24
  • 2陈仁涉,高芳坤,魏洁.微量白蛋白尿的发生机理、预后及治疗[J].国外医学(临床生物化学与检验学分册),1997,18(4):156-158. 被引量:52
  • 3[1]Grenfell A, Watkins PJ. Clinical diabetic Nephropath naturalhistory and complication [J]. Clin Endocrinol Metab, 1986, 15:783
  • 4[3]Makino H, Ikeda S, Haramoto T, et al. Heparan sulfate proteoglycans are lost in patients with diabetic Nephropathy[J]. Nephron, 1992, 61:415
  • 5[5]Yu H,Yanagisawa Y,Forbes MA,et al.α1 - microglo bulin,aindicator protein for renal tubular function[J ] .J Clin Pathol,1983, 36(3) :253
  • 6[6]Cooper EH, Forbes MA, Crockson RA, et al. Proximal renaltubular function in myelomatosis[J] .J Clin Pathol, 1984, 37(8) :852
  • 7[7]Parving HH,Andersen AR,Smibt UM,et al. Effect of antihypertensive treatment on kidney function in diabeticnephropathy[J ]. Br Med J, 1997, 294(6): 1443
  • 8[8]Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults[J ] . N Engl J Med, 1999,340: 14
  • 9[9]Mattock MB,Morrish NJ,Viberti GC,et al. Prospective studyof microalbuminuria as predictor of mortality in NIDDM[J] .Diabetes, 1992, 41: 736
  • 10[10]Schmitz A, Vath M.Microalbuminmia:a major risk factor innon - insulin - dependent diabetes. A 10 - year follow - upstudy of 503 patients [ J ]. Diabetic Med, 1988, 5: 126

共引文献222

同被引文献26

  • 1Mora-Fernandez C, Dominguez-Pimentel V, de Fuent- es MM,et al. Diabetic kidney disease: from physiolo- gy to therapeutics [J]. J Physiology, 2014, 592 (Pt 18) :3997-4012.
  • 2Yang L, Ma J, Zhang X, et al. Protective role of the vitamin D receptor[J]. Cell Immunol, 2012,279 (2) : 160-166.
  • 3Moliteh M, De Fronzo RA, Franz MJ, et al. Nephropa- thy in diabetes[J]. Diabetes Care, 2004,27 (Suppl 1 ) : S79-83.
  • 4Bendik I,Friedel A,Roos FF,et al. Vitamin D..a criti- cal and essential micronutrient for human health[J]. Front Physiol,2014(5) :248.
  • 5Li YC. Podocytes as target of vitamin D~J]. Curt Dia- betes Rev,2011,7(1) :35-40.
  • 6Fernandez-Juarez G, Luno J, Barrio V, et al. 25 (OH) vitamin D levels and renal disease progression in pa- tients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system[J]. Clinical Journal of the American Society of Nephrology, 2013,8 ( 11 ) : 1870-1876.
  • 7Santoro D, Caccamo D, Lucisano S, et al. Interplay of vitamin D, erythropoiesis, and the reninangiotensin system[J]. Biomed Res Int,2015(2015) :145828.
  • 8Lan F. The application of urinary transferrin and Cys- tatin C joint detection in early diagnosis of primary glomerular nephritis [J]. Laboratory Medicine and Clinic, 2014,11 (2): 234-235.
  • 9Holzscheiter L, Beck C, Rutz S, et al. NGAL, L- FABP, and KIM-1 in comparison to established markers of renal dysfunction [J]. Clin Chem Lab Med,2014,52(4) : 537-546.
  • 10毛达勇,喻飞,张吉才.糖尿病肾病患者铁代谢的研究[J].现代检验医学杂志,2011,26(4):105-107. 被引量:4

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部